These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

50 related articles for article (PubMed ID: 7368135)

  • 1. Blood component therapy: red blood cells.
    Patten E
    Tex Med; 1980 Feb; 76(2):56-9. PubMed ID: 7368135
    [No Abstract]   [Full Text] [Related]  

  • 2. Component therapy.
    Rock G
    Can Nurse; 1974 Sep; 70(9):24-7. PubMed ID: 4434353
    [No Abstract]   [Full Text] [Related]  

  • 3. Leukocyte-poor red blood cells (washed) prevent transfusion reactions.
    Palermo GJ; Bove JR
    Conn Med; 1981 Dec; 45(12):753-4. PubMed ID: 7307514
    [No Abstract]   [Full Text] [Related]  

  • 4. [Appearance of iso-antibodies against the blood platelets, leukocytes and erythrocytes after blood transfusion].
    WALEWSKA I; GULMANTOWICZ A; KACPERSKA E; FRANKOWSKA K; CHOJNACKA I; KALINSKA J; SENDYSN
    Pol Tyg Lek; 1961 Aug; 16():1262-7. PubMed ID: 14004546
    [No Abstract]   [Full Text] [Related]  

  • 5. [Fresh blood or its components for a directed transfusion therapy].
    Ehrich CC
    Anaesthesist; 1973 Jun; 22(6):274-5. PubMed ID: 4725652
    [No Abstract]   [Full Text] [Related]  

  • 6. [Mechanical donation of whole blood simultaneous extraction of concentrated erythrocytes and fresh plasma using MCS-3P].
    Matthes G; Richter E; Tofoté U; Pawlow I
    Beitr Infusionsther Transfusionsmed; 1994; 32():9-11. PubMed ID: 9480165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Therapy with blood and blood products].
    Lakartidningen; 1972 Dec; 69():Suppl 4:53-4. PubMed ID: 4656850
    [No Abstract]   [Full Text] [Related]  

  • 8. Current issues in transfusion medicine in Norway.
    Flesland O; Seghatchian J
    Transfus Apher Sci; 2005 Feb; 32(1):7-10. PubMed ID: 15737866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Thawed erythrocytes as a new filler in the apparatus for extracorporeal circulation].
    Rudaev IaA; Fedorova LI; Lifliandskiĭ DB; Batukaev AI; Semenova NV
    Probl Gematol Pereliv Krovi; 1970 Jul; 15(7):3-5. PubMed ID: 5484231
    [No Abstract]   [Full Text] [Related]  

  • 10. Leukocyte depletion for safe blood transfusion.
    Singh S; Kumar A
    Biotechnol J; 2009 Aug; 4(8):1140-51. PubMed ID: 19418471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blood transfusion.
    Mollison PL; Engelfriet P
    Semin Hematol; 1999 Oct; 36(4 Suppl 7):48-58. PubMed ID: 10595754
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improved flow cytometric method to enumerate residual cells: minimal linear detection limits for platelets, erythrocytes, and leukocytes.
    Pichler J; Printz D; Scharner D; Trbojevic D; Siekmann J; Fritsch G
    Cytometry; 2002 Aug; 50(4):231-7. PubMed ID: 12210603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Transfusion of sedimented red cells and transfusion reaction].
    KIM SM
    Taehan Oekwa Hakhoe Chapchi; 1962 Nov; 4():763-72. PubMed ID: 14032680
    [No Abstract]   [Full Text] [Related]  

  • 14. The effects of leukoreduced blood transfusion on infection risk following injury: a randomized controlled trial.
    Nathens AB; Nester TA; Rubenfeld GD; Nirula R; Gernsheimer TB
    Shock; 2006 Oct; 26(4):342-7. PubMed ID: 16980879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Blood component therapy (author's transl)].
    Kretschmer V
    Anasth Intensivther Notfallmed; 1980 Jun; 15(3):189-200. PubMed ID: 7468950
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The current potentials for optimal whole-blood transfusion and component therapy with blood products--erythrocytes in obstetrics and gynecology--the indications, means and methods].
    Nikolov A; Kovachev I; Gŭrcheva L; Dimitrov A
    Akush Ginekol (Sofiia); 1998; 37(4):46-9. PubMed ID: 10360055
    [No Abstract]   [Full Text] [Related]  

  • 17. Practice Guidelines for blood component therapy: A report by the American Society of Anesthesiologists Task Force on Blood Component Therapy.
    Anesthesiology; 1996 Mar; 84(3):732-47. PubMed ID: 8659805
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Characterization of 24-hour survival rate and duration of survival of hydroxyethyl starch cryopreserved erythrocytes after autologous transfusion in the dog].
    Langer R; Albrecht R; Hempel K; Krug S; Sputtek A; Steigerwald R; Trenkel K; Henrich HA
    Infusionsther Transfusionsmed; 1994 Dec; 21(6):393-400. PubMed ID: 7533015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Salvaging of liquid-preserved O-positive and O-negative red blood cells by rejuvenation and freezing.
    Ragno G; Robert Valeri C
    Transfus Apher Sci; 2006 Oct; 35(2):137-43. PubMed ID: 17035090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prion protein and the red cell.
    Anstee DJ
    Curr Opin Hematol; 2007 May; 14(3):210-4. PubMed ID: 17414209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.